In Case You Missed It
5 Things You Must Know Before the Market Opens
Jim Cramer's Daily Booyah
Winners & Losers
You must accept that the current value is not the price that you paid, but rather the price that you would realize upon sale.
Investment miscues can be just as important as successes, provided we carry lessons away from them.
These names frequently trade at low multiples to current assets and may (but may not) be worthy of purchase.
Just five non-biotech names trade below net current asset value.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.